Other Titles
Respiratory related illness and care [Session]
Abstract
Session presented on Tuesday, November 10, 2015:
Background: Traditional sedation for mechanically ventilated patients causes delirium which increases the patients' length of stay while hospitalized. When extubation is attempted, these medications must be discontinued due to the side effect of respiratory depression, leaving patients anxious and agitated, delaying extubation and prolonging the need for mechanical ventilation. Dexmedetomidine is an alternative sedative that does not cause delirium or respiratory depression. During the weaning process, dexmedetomidine can be continued, allowing the patient to remain calm and successfully extubated.
Objectives: To decrease the length of stay for mechanically ventilated patients by implementing a dexmedetomidine protocol for difficult to extubate patients during the weaning process.
Methods: A pre/post design study was done comparing the patient mean of length of stay on mechanical ventilation. A Mann-Whitney U-Test was used due to the small sample size.
Results: Over the three-month implementation period, 15 patients received dexmedetomidine. None of the patients experienced adverse reactions while on dexmedetomidine. There was a trend of decreasing mechanical ventilation length of stay but no significant difference was noted between the pre-implementation group and the post.
Conclusion: Dexmedetomidine was a safe alternative to traditional sedation for difficult to extubate patients when a bolus dose was not given.
Sigma Membership
Eta Alpha
Type
Presentation
Format Type
Text-based Document
Study Design/Type
N/A
Research Approach
N/A
Keywords:
Dexmedetomidine, Mechanical Ventilation, Sedation
Recommended Citation
Becker, Susan E., "Fewer ventilator days with dexmedetomidine use for patients difficult to extubate implementation study" (2016). Convention. 351.
https://www.sigmarepository.org/convention/2015/presentations_2015/351
Conference Name
43rd Biennial Convention
Conference Host
Sigma Theta Tau International
Conference Location
Las Vegas, Nevada, USA
Conference Year
2015
Rights Holder
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
Acquisition
Proxy-submission
Fewer ventilator days with dexmedetomidine use for patients difficult to extubate implementation study
Las Vegas, Nevada, USA
Session presented on Tuesday, November 10, 2015:
Background: Traditional sedation for mechanically ventilated patients causes delirium which increases the patients' length of stay while hospitalized. When extubation is attempted, these medications must be discontinued due to the side effect of respiratory depression, leaving patients anxious and agitated, delaying extubation and prolonging the need for mechanical ventilation. Dexmedetomidine is an alternative sedative that does not cause delirium or respiratory depression. During the weaning process, dexmedetomidine can be continued, allowing the patient to remain calm and successfully extubated.
Objectives: To decrease the length of stay for mechanically ventilated patients by implementing a dexmedetomidine protocol for difficult to extubate patients during the weaning process.
Methods: A pre/post design study was done comparing the patient mean of length of stay on mechanical ventilation. A Mann-Whitney U-Test was used due to the small sample size.
Results: Over the three-month implementation period, 15 patients received dexmedetomidine. None of the patients experienced adverse reactions while on dexmedetomidine. There was a trend of decreasing mechanical ventilation length of stay but no significant difference was noted between the pre-implementation group and the post.
Conclusion: Dexmedetomidine was a safe alternative to traditional sedation for difficult to extubate patients when a bolus dose was not given.
Description
43rd Biennial Convention 2015 Theme: Serve Locally, Transform Regionally, Lead Globally.